[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N') Diiodoplatinum

[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N') Diiodoplatinum, also known as cisplatin, is a chemotherapy drug used to treat various types of cancer such as lung, bladder, and ovarian cancer. It is a platinum-based compound that works by interfering with DNA replication and cell division, ultimately leading to cell death. Cisplatin is typically administered intravenously under medical supervision. The dosage and frequency of treatment will depend on factors such as the type and stage of cancer, the patient's overall health, and any other medications they may be taking. Patients may experience side effects such as nausea, vomiting, and hair loss, but these can often be managed with medication and other supportive measures. In terms of chemical information, cisplatin has a molecular formula of C6H14N2PtI2 and a molecular weight of 397.28 g/mol. It has a complex structure consisting of a platinum atom bound to two iodine atoms and two amine groups from the cyclohexanediamine ligand. Its mechanism of action involves forming covalent bonds with DNA, leading to the formation of intrastrand and interstrand crosslinks that disrupt DNA replication and cause apoptosis. Overall, cisplatin is a powerful chemotherapy drug that has helped many patients in the fight against cancer. However, it is important to use this medication only under the guidance of a qualified healthcare provider and to carefully monitor for any potential side effects or complications.